METFORMIN HCL and DYSPNOEA

Overview

DYSPNOEA is the #11 most commonly reported adverse reaction for METFORMIN HCL, manufactured by Ascend Laboratories, LLC. There are 1,931 FDA adverse event reports linking METFORMIN HCL to DYSPNOEA. This represents approximately 1.8% of all 105,459 adverse event reports for this drug.

Patients taking METFORMIN HCL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for METFORMIN HCL, but still significant enough to appear in the safety profile.

Other Side Effects of METFORMIN HCL

In addition to dyspnoea, the following adverse reactions have been reported for METFORMIN HCL:

• BLOOD GLUCOSE INCREASED — 6,971 reports
• NAUSEA — 5,684 reports
• WEIGHT DECREASED — 4,121 reports
• DIARRHOEA — 3,578 reports
• VOMITING — 2,956 reports
• DRUG INEFFECTIVE — 2,554 reports
• FATIGUE — 2,449 reports
• DIZZINESS — 2,288 reports
• DECREASED APPETITE — 2,253 reports
• BLOOD GLUCOSE DECREASED — 2,034 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does METFORMIN HCL cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 1,931 FDA reports for METFORMIN HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with METFORMIN HCL?

DYSPNOEA accounts for approximately 1.8% of all adverse event reports for METFORMIN HCL, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking METFORMIN HCL?

If you experience dyspnoea while taking METFORMIN HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages